Sophie Testa to Case-Control Studies
This is a "connection" page, showing publications Sophie Testa has written about Case-Control Studies.
Connection Strength
0.025
-
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study. Int J Infect Dis. 2021 Mar; 104:433-440.
Score: 0.014
-
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine (Baltimore). 2016 Dec; 95(52):e5451.
Score: 0.011